Inflammation : a link between metabolic syndrome and osteoarthritis?

Gierman, L.M. (2013)

Doctoral Thesis

Osteoarthritis (OA) is a frequently occurring joint disorder with great impact on the quality of life. In general, OA is described as a heterogeneous disease with degeneration of articular cartilage as main outcome. Despite extensive research on the pathogenesis of OA, there is until now no cure and treatments are primarily aimed at reducing pain. Evidence starts to appear that mild inflammation and obesity-related biochemical changes are involved in OA pathology. It is uncertain what the relative contribution of these processes is and if they characterize a certain type of OA patients. We identified obesity, high cholesterol and systemic inflammation associated with these conditions as major players in OA development, which may activate joint tissues to secrete inflammatory mediators and contribute to the initiation and progression of OA. Our work suggests that a stratification of OA patients with (features of) the metabolic syndrome as underlying mechanism is recommendable, to optimize the efficacy of clinical trials. Approaching OA as a disease induced by whole body metabolism, and integrating knowledge about different potentially active tissues in the OA process, will provide new insights for possible pharmacological interventions.

• Infra patellar fat pad
• Synovium
• In vitro models
• Animal models
• Obesity
• Metabolic syndrome
• Inflammation
• Osteoarthritis

• All authors: Gierman, L.M.
• Supervisor: Huizinga, T.W.J.
• Co-supervisor: Zuurmond, A.M.
• Qualification: Doctor (dr.)
• Awarding Institution: Leiden University Medical Center (LUMC), Leiden University
• Date: 2013-06-18
• ISBN (print): 9789461084606
• Sponsorship: TiPharma